Action Medical Research and LifeArc announce joint funding awards for translational research into children’s rare diseases
Third joint funding round of up to £1 million
LifeArc’s Opportunity Assessment Group (OAG) team played a vital role in supporting the UK’s #COVID19 #Theraputics… https://t.co/qkgycA5TOe
LifeArc invests in Cumulus Neuroscience
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care
Applications are now open for the Novartis BIOME UK HealthHub 21 Challenge, in collaboration with KQ Labs…
Repurposing drugs: the opportunity and the challenges
Catriona Crombie outlines the case studies from our seminar on drug repurposing
LifeArc appoints Dr Linda Bradley to head up business development
Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.
LifeArc, MRC and BBSRC create £18m network of gene therapy hubs to advance promising research into new treatments for patients
Hubs will be at King’s College London, NHS Blood and Transplant in Bristol and the University of Sheffield
The pandemic – a driving force for innovation in diagnostics?
Ciaran Fulton, Head of Diagnostics, reflects on the rapid evolution of diagnostics during the pandemic.
KQ Labs announces the graduation of its third cohort in a highly successful Demo Day event
KQ Labs will be opening its next cohort for applications in early May 2021
International Women’s Day 2021 – salute to women trailblazing innovation
Anji Miller, Senior Business Manager and advocate for diversity, discusses representation in science for International Women's Day 2021.